BIO-PATH HOLDINGS, INC. (BPTH): debt financing — Bio-Path issues $161K promissory note to Quick Capital; default-conversion at 65% of low bid

BIO-PATH HOLDINGS, INC.

Principal $161K, purchase price $140K after $21K original issue discount.
12% one-time interest; five payments from Oct 2025 to Feb 2026 ($90,160 first, then $22,540 each).
Upon default, conversion at 65% of lowest closing bid price over 10 prior trading days; default penalty 150% plus 22% interest.
Unregistered sale under Rule 506(b) / Section 4(a)(2); use of proceeds for working capital.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

BIO-PATH HOLDINGS, INC. incurred loan of $161,000 with Quick Capital, LLC at twelve percent.

Instrument: loan
Principal: $161,000
Counterparty: Quick Capital, LLC
Rate: twelve percent
Event: incurrence

Exact text from the filing

On April 28, 2025, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Quick Capital, LLC, a Wyoming limited liability company (the “Lender”), an accredited investor, for the issuance and sale of a promissory note in the aggregate principal amount of $161,000

View on SEC.gov

102 debt financings filed in the last 30 days. Browse all debt financings →

BIO-PATH HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-041256

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.